118 related articles for article (PubMed ID: 10619731)
21. [Surveillance of invasive mold infections in lung transplant recipients: effect of antimycotic prophylaxis with itraconazole and voriconazole].
Mattner F; Chaberny IF; Weissbrodt H; Fischer S; Gastmeier P; Haubitz B; Gottlieb J; Mattner L; Strueber M
Mycoses; 2005; 48 Suppl 1():51-5. PubMed ID: 15826288
[TBL] [Abstract][Full Text] [Related]
22. An EORTC multicentre prospective survey of invasive aspergillosis in haematological patients: diagnosis and therapeutic outcome. EORTC Invasive Fungal Infections Cooperative Group.
Denning DW; Marinus A; Cohen J; Spence D; Herbrecht R; Pagano L; Kibbler C; Kcrmery V; Offner F; Cordonnier C; Jehn U; Ellis M; Collette L; Sylvester R
J Infect; 1998 Sep; 37(2):173-80. PubMed ID: 9821093
[TBL] [Abstract][Full Text] [Related]
23. Invasive pulmonary aspergillosis in neutropenic patients during hospital construction: before and after chemoprophylaxis and institution of HEPA filters.
Oren I; Haddad N; Finkelstein R; Rowe JM
Am J Hematol; 2001 Apr; 66(4):257-62. PubMed ID: 11279636
[TBL] [Abstract][Full Text] [Related]
24. Invasive aspergillosis in a paediatric haematology department: a 15-year review.
Crassard N; Hadden H; Piens MA; Pondarré C; Hadden R; Galambrun C; Pracros JP; Souillet G; Basset T; Berthier JC; Philippe N; Bertrand Y
Mycoses; 2008 Mar; 51(2):109-16. PubMed ID: 18254746
[TBL] [Abstract][Full Text] [Related]
25. Invasive aspergillosis caused by Aspergillus terreus: an emerging opportunistic infection with poor outcome independent of azole therapy.
Hachem R; Gomes MZ; El Helou G; El Zakhem A; Kassis C; Ramos E; Jiang Y; Chaftari AM; Raad II
J Antimicrob Chemother; 2014 Nov; 69(11):3148-55. PubMed ID: 25006241
[TBL] [Abstract][Full Text] [Related]
26. Clinical characteristics and treatment outcomes of chronic necrotizing pulmonary aspergillosis: a review of 43 cases.
Nam HS; Jeon K; Um SW; Suh GY; Chung MP; Kim H; Kwon OJ; Koh WJ
Int J Infect Dis; 2010 Jun; 14(6):e479-82. PubMed ID: 19910234
[TBL] [Abstract][Full Text] [Related]
27. A survey of anti-fungal management in lung transplantation.
Dummer JS; Lazariashvilli N; Barnes J; Ninan M; Milstone AP
J Heart Lung Transplant; 2004 Dec; 23(12):1376-81. PubMed ID: 15607667
[TBL] [Abstract][Full Text] [Related]
28. Outcome and medical costs of patients with invasive aspergillosis and acute myelogenous leukemia-myelodysplastic syndrome treated with intensive chemotherapy: an observational study.
Slobbe L; Polinder S; Doorduijn JK; Lugtenburg PJ; el Barzouhi A; Steyerberg EW; Rijnders BJ
Clin Infect Dis; 2008 Dec; 47(12):1507-12. PubMed ID: 18990068
[TBL] [Abstract][Full Text] [Related]
29. Treatment of invasive fungal sinusitis with liposomal amphotericin B: a report of four cases.
Sungkanuparph S; Sathapatayavongs B; Kunachak S; Luxameechanporn T; Cheewaruangroj W
J Med Assoc Thai; 2001 Apr; 84(4):593-601. PubMed ID: 11460976
[TBL] [Abstract][Full Text] [Related]
30. [Diagnosis and treatment of invasive aspergillosis infection following orthotopic liver transplantation].
Yi SH; Chen GH; Lu MQ; Yang Y; Cai CJ; Xu C; Li H; Wang GS; Yi HM
Zhonghua Wai Ke Za Zhi; 2006 Jul; 44(13):885-8. PubMed ID: 17067477
[TBL] [Abstract][Full Text] [Related]
31. The evolution and evaluation of a whole blood polymerase chain reaction assay for the detection of invasive aspergillosis in hematology patients in a routine clinical setting.
White PL; Linton CJ; Perry MD; Johnson EM; Barnes RA
Clin Infect Dis; 2006 Feb; 42(4):479-86. PubMed ID: 16421791
[TBL] [Abstract][Full Text] [Related]
32. Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey.
Cornillet A; Camus C; Nimubona S; Gandemer V; Tattevin P; Belleguic C; Chevrier S; Meunier C; Lebert C; Aupée M; Caulet-Maugendre S; Faucheux M; Lelong B; Leray E; Guiguen C; Gangneux JP
Clin Infect Dis; 2006 Sep; 43(5):577-84. PubMed ID: 16886149
[TBL] [Abstract][Full Text] [Related]
33. Treatment and outcome of invasive Aspergillus infections in allogeneic BMT recipients.
Jantunen E; Ruutu P; Piilonen A; Volin L; Parkkali T; Ruutu T
Bone Marrow Transplant; 2000 Oct; 26(7):759-62. PubMed ID: 11042657
[TBL] [Abstract][Full Text] [Related]
34. Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcome.
Patterson TF; Boucher HW; Herbrecht R; Denning DW; Lortholary O; Ribaud P; Rubin RH; Wingard JR; DePauw B; Schlamm HT; Troke P; Bennett JE; ;
Clin Infect Dis; 2005 Nov; 41(10):1448-52. PubMed ID: 16231256
[TBL] [Abstract][Full Text] [Related]
35. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.
Neofytos D; Horn D; Anaissie E; Steinbach W; Olyaei A; Fishman J; Pfaller M; Chang C; Webster K; Marr K
Clin Infect Dis; 2009 Feb; 48(3):265-73. PubMed ID: 19115967
[TBL] [Abstract][Full Text] [Related]
36. Liposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infections during induction chemotherapy for patients with acute myelogenous leukemia and myelodysplastic syndrome.
Mattiuzzi GN; Estey E; Raad I; Giles F; Cortes J; Shen Y; Kontoyiannis D; Koller C; Munsell M; Beran M; Kantarjian H
Cancer; 2003 Jan; 97(2):450-6. PubMed ID: 12518369
[TBL] [Abstract][Full Text] [Related]
37. Central nervous system aspergillosis in allogeneic stem cell transplant recipients.
Jantunen E; Volin L; Salonen O; Piilonen A; Parkkali T; Anttila VJ; Paetau A; Ruutu T
Bone Marrow Transplant; 2003 Feb; 31(3):191-6. PubMed ID: 12621480
[TBL] [Abstract][Full Text] [Related]
38. Combination and sequential antifungal therapy for invasive aspergillosis: review of published in vitro and in vivo interactions and 6281 clinical cases from 1966 to 2001.
Steinbach WJ; Stevens DA; Denning DW
Clin Infect Dis; 2003 Oct; 37 Suppl 3():S188-224. PubMed ID: 12975752
[TBL] [Abstract][Full Text] [Related]
39. Invasive pulmonary aspergillosis in patients with hematologic malignancies: survival and prognostic factors.
Subirà M; Martino R; Franquet T; Puzo C; Altés A; Sureda A; Brunet S; Sierra J
Haematologica; 2002 May; 87(5):528-34. PubMed ID: 12010668
[TBL] [Abstract][Full Text] [Related]
40. Endoscopic surgery for sinonasal invasive aspergillosis in bone marrow transplantation patients.
Eliashar R; Resnick IB; Goldfarb A; Wohlgelernter J; Gross M
Laryngoscope; 2007 Jan; 117(1):78-81. PubMed ID: 17135980
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]